Zidovudine Injection Clinical Trials

• A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
  ClinicalTrials.gov Identifier: NCT00000662 - Active, not recruiting
  HIV Infections
  
• A Comparison of Zidovudine (AZT) Used Alone or in Combination with Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001022 - Active, not recruiting
  HIV Infections
  
• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
  ClinicalTrials.gov Identifier: NCT00000864 - Active, not recruiting
  HIV Infections
  
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00086359 - Active, not recruiting
  HIV Infections
  
• A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
  ClinicalTrials.gov Identifier: NCT00000862 - Active, not recruiting
  HIV Infections; Pregnancy
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
  ClinicalTrials.gov Identifier: NCT00000652 - Active, not recruiting
  HIV Infections
  
• Zidovudine and Lamivudine Given Once Versus Twice Daily
  ClinicalTrials.gov Identifier: NCT00014014 - Active, not recruiting
  HIV Infections
  
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000887 - Active, not recruiting
  HIV Infections; Pregnancy
  
• An Open-Label Study of Nevirapine Plus Zidovudine (ZDV) and 3TC Treatment in Women Who Have Previously Received a Nevirapine Regimen for the Prevention of Mother to Child Transmission (pMTCT) of HIV-1.
  ClinicalTrials.gov Identifier: NCT00144157 - Active, not recruiting
  Acquired Immunodeficiency Syndrome
  
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000944 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
  ClinicalTrials.gov Identifier: NCT00004981 - Active, not recruiting
  HIV Infections
  
• Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00006617 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) with Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00011895 - Active, not recruiting
  HIV Infections
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
  HIV Infections
  
• PI Vs. NNRTI Based Therapy for HIV Advanced Disease
  ClinicalTrials.gov Identifier: NCT00162643 - Recruiting
  Acquired Immunodeficiency Syndrome
  
• Trial of UK-427,857 in Combination with Zidovudine/Lamivudine versus Efavirenz in Combination with Zidovudine/Lamivudine for the Treatment of HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00098293 - Active, not recruiting
  HIV Infection
  
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
  ClinicalTrials.gov Identifier: NCT00000976 - Completed
  HIV Infections
  
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
  ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Study of Zidovudine/Lamivudine and Nevirapine for Reduction of Mother-to-Child HIV Transmission During Breastfeeding
  ClinicalTrials.gov Identifier: NCT00146380 - Recruiting
  HIV Infections
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
  ClinicalTrials.gov Identifier: NCT00000682 - Completed
  HIV Infections
  
• A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
  ClinicalTrials.gov Identifier: NCT00000712 - Completed
  HIV Infections
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children
  ClinicalTrials.gov Identifier: NCT00001066 - Completed
  HIV Infections
  
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults and Adolescents in Senegal
  ClinicalTrials.gov Identifier: NCT00100568 - Not yet recruiting
  HIV Infections
  
• A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of P
  ClinicalTrials.gov Identifier: NCT00002323 - Completed
  HIV Infections
  
• Double-Blind Comparison of the Efficacy of Continued Zidovudine versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment with Zidovudine
  ClinicalTrials.gov Identifier: NCT00002035 - Completed
  HIV Infections
  
• A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
  ClinicalTrials.gov Identifier: NCT00000671 - Completed
  HIV Infections
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
  ClinicalTrials.gov Identifier: NCT00002320 - Completed
  HIV Infections
  
• A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
  ClinicalTrials.gov Identifier: NCT00000897 - Completed
  HIV Infections
  
• NRTI-Sparing Pilot Study
  ClinicalTrials.gov Identifier: NCT00143689 - Active, not recruiting
  HIV; Mitochondrial Toxicity
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00470041 - Recruiting
  Healthy
  
• Treatment with Combinations of Several Antiviral Drugs in Infants and Young Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00000872 - Active, not recruiting
  HIV Infections
  
• Treatment with Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
  ClinicalTrials.gov Identifier: NCT00000923 - Active, not recruiting
  HIV Infections
  
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
  ClinicalTrials.gov Identifier: NCT00002371 - Completed
  HIV Infections
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
  ClinicalTrials.gov Identifier: NCT00000969 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
  ClinicalTrials.gov Identifier: NCT00102960 - Active, not recruiting
  HIV Infections
  
• Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
  ClinicalTrials.gov Identifier: NCT00001644 - Active, not recruiting
  HIV Infection
  
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
  ClinicalTrials.gov Identifier: NCT00050895 - Active, not recruiting
  HIV Infections
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• Safety and Tolerance of Zidovudine with Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
  ClinicalTrials.gov Identifier: NCT00000670 - Completed
  HIV Infections
  
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
  ClinicalTrials.gov Identifier: NCT00102206 - Active, not recruiting
  HIV Infections
  
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children with Prior Treatment
  ClinicalTrials.gov Identifier: NCT00000902 - Active, not recruiting
  HIV Infections
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
  ClinicalTrials.gov Identifier: NCT00270283 - Active, not recruiting
  Acquired Immunodeficiency Syndrome; Anemia
  
• Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
  ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
  HIV Infections
  
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
  ClinicalTrials.gov Identifier: NCT00000952 - Active, not recruiting
  HIV Infections
  
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
  ClinicalTrials.gov Identifier: NCT00013520 - Completed
  HIV Infections
  
• Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
  ClinicalTrials.gov Identifier: NCT00005002 - Active, not recruiting
  HIV Infections
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
  ClinicalTrials.gov Identifier: NCT00142337 - Active, not recruiting
  HIV; Postpartum Period
  
• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
  ClinicalTrials.gov Identifier: NCT00270270 - Active, not recruiting
  Acquired Immunodeficiency Syndrome; Anemia
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Treatment with Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005000 - Active, not recruiting
  HIV Infections
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
  ClinicalTrials.gov Identifier: NCT00000770 - Completed
  HIV Infections
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination with Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000878 - Active, not recruiting
  HIV Infections; Pregnancy
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
  ClinicalTrials.gov Identifier: NCT00471614 - Recruiting
  HIV Infections; Insulin Resistance; Hyperlactatemia
  
• Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002905 - Active, not recruiting
  AIDS-related peripheral/systemic lymphoma
  
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children (Ages 2- <12)
  ClinicalTrials.gov Identifier: NCT00528957 - Recruiting
  HIV Infections
  
• MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
  ClinicalTrials.gov Identifier: NCT00122226 - Active, not recruiting
  HIV Infections; HIV-Associated Lipodystrophy Syndrome
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• The Safety and Effectiveness of Zidovudine in the Treatment of Patients with Early AIDS Related Complex
  ClinicalTrials.gov Identifier: NCT00001011 - Completed
  HIV Infections
  
• Zidovudine Levels in HIV Infected Patients Being Treated for HCV
  ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00112047 - Active, not recruiting
  HIV Infections
  
• Evaluation of Patients Who Have Not Had Success with Zidovudine
  ClinicalTrials.gov Identifier: NCT00001025 - Completed
  HIV Infections
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More than 12 Weeks
  ClinicalTrials.gov Identifier: NCT00001063 - Completed
  HIV Infections
  
• Open-Label Program of Dideoxycytidine ( ddC ) to be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
  ClinicalTrials.gov Identifier: NCT00002081 - Completed
  HIV Infections
  
• A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00001005 - Completed
  HIV Infections
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients with AIDS and Advanced ARC
  ClinicalTrials.gov Identifier: NCT00000999 - Completed
  HIV Infections
  
• The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children with Mild to Moderate Symptoms
  ClinicalTrials.gov Identifier: NCT00000990 - Completed
  HIV Infections
  
• A Study of 141W94 Used Alone or in Combination with Zidovudine Plus 3TC in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001085 - Completed
  HIV Infections
  
• A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
  ClinicalTrials.gov Identifier: NCT00000855 - Completed
  HIV Infections
  
• A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
  ClinicalTrials.gov Identifier: NCT00000719 - Completed
  HIV Infections
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma